Innovation Drives Gains in Biotech Stocks
Innovation Drives Gains in SMID Biotech Stocks Our SMID Biotech Model continues to churn out winners- innovation resides in small cap stocks. ASCO data has confirmed Value of Precision Oncology, genomics and use of MRDs for tracking therapies. Drivers are clinical data, partnerships and...
Biotech Stocks Gain Momentum with Prospects for a Good Week…Update-4 Rotation Week into Biotech
6/29/26….We will update SMID cap biotechs tomorrow but you should review our January summary post after the JPMorgan Healthcare Conference. 6/27/26 ,,,Update-4: A Big Week for Biotech and Healthcare in a down market with the XLK down 5.4%. XBI up 10.4%, IBB up 7.6%, XLV up 7.3%, ARKG up...
Market: After Frothy Friday Comes Manic Monday !…Update-3 New highs for SMID biotech
Update-3 …7/19/26….A bit of a roller coaster week but ending on a positive note.Stocks come back strong after a brief Wednesday sell-off; market assumes worst is over with IRAN War and Crude is down leaving energy sector weak. Technology stocks are volatile but you have to stay...
Tech Stock Momentum Wanes but SMID Biotech Has Momentum within a Rising Healthcare Sector…Update-2. rally time!
Update-2…6/11/26–11:25 AM...Green Screen Day in SMID Biotechs: XBI up over 2%, IWM up1.3%, ARKG up 0.8% …bingo! Some 2%+ SMID movers: ADPT, AMRX, AXSM, CYTK, DNTH, INCY. XNCR. Large cap 2.5% + movers: GILD, PFE, NVS Update-1…6/10/26…The WAR will go on with no peace...
SMID Biotech Momentum Has Begun with Several Breakouts…Update-3 TECH Sell off!
Update-3 6/7/26….Update after massive NASDAQ and Information Technology sell-off: The XLK fell 6.66% on 6/5 to $180.30.Strong support at $172. Strongest holdings AAPL and NVDA. Down 5.61% for week.Up 25.2% YTD. THe XLV was up 0.61% on 6/5 to $153.Strong support at $146. Strongest...